Literature DB >> 16088181

Commercial fibrin sealants are not equivalent in a rabbit liver-resection model which quantitatively evaluates hemostasis and formation of adhesions.

I Nur1, Y Lyahovetsky, L Bar, M Schon.   

Abstract

A rabbit partial liver resection model was used to determine the hemostatic effectiveness of a new fibrin sealant. Persistent bleeding, with a mean bleeding time of 372 s and blood loss of 18 ml, from a resected lobe of the liver was achieved after rabbits in the untreated control group had been infused continuously with unfractionated heparin over 20 min with 0.2 IU/ml at a rate of 1 ml/min. Spraying the resected surface with the new fibrin sealant, Quixil, reduced bleeding to < 1 ml and the post-resection bleeding times was 25 s. Bleeding time, blood loss and the volume of sealant used in the rabbit model were inversely correlated with the thrombin concentration in the sealant. In direct comparisons with Tissucol and Beriplast, Quixil was associated with the shortest bleeding times, the lowest volume of sealant used and the lowest score of abdominal adhesions. Copyright 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16088181     DOI: 10.1159/000085963

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  5 in total

1.  Laparoscopic spray application of fibrin sealant effects on hemodynamics and spray efficiency at various application pressures and distances.

Authors:  K T Druckrey-Fiskaaen; M W W Janssen; L Omidi; N Polze; U Kaisers; I Nur; E Goldberg; G Bokel; J Hauss; Michael R Schön
Journal:  Surg Endosc       Date:  2007-02-21       Impact factor: 4.584

2.  Effects of primary suture and fibrin sealant on hemostasis and liver regeneration in an experimental liver injury.

Authors:  Arif Hakan Demirel; Ozgur Taylan Basar; Ali Ulvi Ongoren; Erkut Bayram; Mustafa Kisakurek
Journal:  World J Gastroenterol       Date:  2008-01-07       Impact factor: 5.742

Review 3.  Fibrin sealant (evicel® [quixil®/crosseal™]): a review of its use as supportive treatment for haemostasis in surgery.

Authors:  Sohita Dhillon
Journal:  Drugs       Date:  2011-10-01       Impact factor: 9.546

4.  The use of fibrin sealant to prevent major complications following laparoscopic gastric bypass: results of a multicenter, randomized trial.

Authors:  Gianfranco Silecchia; Cristian Eugeniu Boru; Jean Mouiel; Marco Rossi; Marco Anselmino; Mario Morino; Mario Toppino; Achille Gaspari; Paolo Gentileschi; Roberto Tacchino; Nicola Basso
Journal:  Surg Endosc       Date:  2008-03-26       Impact factor: 4.584

5.  Comparison of commercial fibrin sealants in facelift surgery: a prospective study.

Authors:  Giovanni Botti; Michele Pascali; Chiara Botti; Florian Bodog; Pietro Gentile; Valerio Cervelli
Journal:  Clin Cosmet Investig Dermatol       Date:  2013-11-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.